A team of investigators will use a new 5-year, $3,479,967 grant from the National Institutes of Health to investigate improved management of patients with sleep-disordered breathing.

“This proposal is based on the premise that insufficient sleep contributes to sleepiness in patients with SDB, and may account for the variability in response to positive-pressure airway therapy in patients with sleepiness and mild SDB,” Dr. Badr said. “The objective is to determine the treatment that results in the greatest benefit to patients in terms of daytime sleepiness, blood pressure and endothelial function.”